M. Siwale

发表

Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa

T. F. Rinke de Wit, P. Reiss, F. Wit, 2018, AIDS.

Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.

T. F. Rinke de Wit, T. S. Boender, C. Kityo, 2016, The Journal of antimicrobial chemotherapy.

Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis

K. Mandaliya, T. S. Boender, C. Kityo, 2022, AIDS.

Plasma Biomarkers of Human Immunodeficiency Virus–Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy

T. F. Rinke de Wit, P. Reiss, F. Wit, 2019, The Journal of infectious diseases.

HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia

T. F. Rinke de Wit, A. Wensing, W. Stevens, 2010, Journal of acquired immune deficiency syndromes.

Socioeconomic and reproductive factors associated with condom use within and outside of marriage among urban pregnant women in Zambia.

C. Kankasa, F. Kasolo, H. Terunuma, 2005, African journal of reproductive health.

HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes

T. F. Rinke de Wit, W. Stevens, R. Hamers, 2013, Journal of acquired immune deficiency syndromes.

Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts

T. F. Rinke de Wit, P. Phanuphak, F. Wit, 2017, Journal of the International AIDS Society.

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.

Kishor Mandaliya, Wendy S Stevens, Raph L Hamers, 2011, The Lancet. Infectious diseases.

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.

F. Wit, K. Mandaliya, C. Kityo, 2012, The Lancet. Infectious diseases.

Eff ect of pretreatment HIV-1 drug resistance on immunological , virological , and drug-resistance outcomes of fi rst-line antiretroviral treatment in sub-Saharan Africa : a multicentre cohort study

K. Mandaliya, C. Kityo, W. Stevens, 2011 .

Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.

T. F. Rinke de Wit, A. Wensing, K. Mandaliya, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.

T. F. Rinke de Wit, K. Mandaliya, C. Kityo, 2012, The Journal of infectious diseases.

COHORT PROFILE Cohort Profile: The PharmAccess African

T. F. Rinke de Wit, P. Phanuphak, Patrick C. K. Li, 2022 .

Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa

T. F. Rinke de Wit, K. Mandaliya, C. Kityo, 2011, Journal of acquired immune deficiency syndromes.

Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.

T. F. Rinke de Wit, K. Mandaliya, T. S. Boender, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

T. F. Rinke de Wit, K. Mandaliya, T. S. Boender, 2018, Scientific Reports.

The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa.

T. F. Rinke de Wit, K. Mandaliya, T. S. Boender, 2020, AIDS.

Optimism alongside new challenges: using a rehabilitation framework to explore experiences of a qualitative longitudinal cohort of people living with HIV on antiretroviral treatment in Lusaka, Zambia

S. Nixon, V. Bond, M. Maimbolwa, 2018, AIDS care.

Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.

T. F. Rinke de Wit, R. Geskus, K. Mandaliya, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.

T. F. Rinke de Wit, C. Chimbetete, K. Mandaliya, 2016, The Journal of infectious diseases.

Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy.

P. Reiss, F. Wit, N. Kootstra, 2020, The Journal of infectious diseases.

Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.

P. Phanuphak, T. R. D. Wit, F. Wit, 2017, Journal of the International AIDS Society.

Drug-resistant HIV-1 in sub-Saharan Africa: clinical and public health studies

K. Mandaliya, C. Kityo, W. Stevens, 2013 .